Home Clinical Research

Clinical Research

TRIGR Therapeutics Announces Formation of Global Clinical & Scientific Advisory Board

New Delhi, May 19, 2019: TRIGR Therapeutics, Inc. ("TRIGR"), a clinical stage biotechnology company focused on the development of multi-targeted and immunomodulatory bispecific antibodies, announced today the formation of its global Clinical and Scientific Advisory Board (CSAB) comprising of 10...